Instil Bio, Inc. (TIL)
5.51
-0.57
(-9.38%)
USD |
NASDAQ |
Nov 16, 15:24
Instil Bio Price : 5.51 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 13, 2026 | 6.202 | 6.495 | 6.02 | 6.08 | 51629.00 |
| Nov 12, 2026 | 6.33 | 6.630 | 6.10 | 6.24 | 98156.00 |
| Nov 11, 2026 | 6.35 | 6.60 | 6.23 | 6.31 | 53339.00 |
| Nov 10, 2026 | 6.42 | 6.86 | 6.343 | 6.35 | 22729.00 |
| Nov 09, 2026 | 6.81 | 6.99 | 6.38 | 6.47 | 32674.00 |
| Nov 06, 2026 | 6.72 | 6.98 | 6.30 | 6.83 | 107046.0 |
| Nov 05, 2026 | 6.85 | 7.125 | 6.70 | 6.99 | 92545.00 |
| Nov 04, 2026 | 6.74 | 7.10 | 6.596 | 6.99 | 75591.00 |
| Nov 03, 2026 | 6.745 | 6.805 | 6.60 | 6.67 | 25282.00 |
| Nov 02, 2026 | 6.73 | 6.91 | 6.51 | 6.55 | 33865.00 |
| Oct 30, 2026 | 6.74 | 6.87 | 6.51 | 6.80 | 25228.00 |
| Oct 29, 2026 | 6.71 | 7.12 | 6.71 | 6.825 | 57660.00 |
| Oct 28, 2026 | 5.85 | 6.93 | 5.85 | 6.79 | 149611.0 |
| Oct 27, 2026 | 5.56 | 6.08 | 5.56 | 5.84 | 102053.0 |
| Oct 26, 2026 | 5.86 | 5.88 | 5.57 | 5.57 | 36689.00 |
| Oct 23, 2026 | 5.76 | 5.90 | 5.66 | 5.84 | 121348.0 |
| Oct 22, 2026 | 5.80 | 5.94 | 5.68 | 5.70 | 84883.00 |
| Oct 21, 2026 | 6.01 | 6.09 | 5.73 | 5.77 | 40868.00 |
| Oct 20, 2026 | 5.88 | 6.19 | 5.85 | 5.94 | 100161.0 |
| Oct 19, 2026 | 5.89 | 6.35 | 5.62 | 5.79 | 147896.0 |
| Oct 16, 2026 | 6.18 | 6.45 | 5.91 | 5.91 | 25174.00 |
| Oct 15, 2026 | 6.08 | 6.495 | 6.08 | 6.13 | 33024.00 |
| Oct 14, 2026 | 6.06 | 6.22 | 5.93 | 5.95 | 44119.00 |
| Oct 13, 2026 | 6.611 | 6.611 | 6.025 | 6.18 | 27606.00 |
| Oct 12, 2026 | 6.65 | 6.66 | 6.51 | 6.58 | 11333.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 18.88 |
| Alnylam Pharmaceuticals, Inc. | 159.64 |
| Anika Therapeutics, Inc. | 12.99 |
| Savara, Inc. | 4.44 |
| Arrowhead Pharmaceuticals, Inc. | 44.69 |
Price Related Metrics
| Price to Book Value | 0.348 |
| Earnings Yield | -81.17% |
| Market Cap | 37.37M |